Animal Vaccines Market to reach USD 15.20 Bn, Globally, by 2030 at 5.2% CAGR: Allied Market Research
Growth in demand for pet insurance and rise in prevalence of animal diseases drive the growth of the global animal vaccines market.
WILMINGTON, DELAWARE, UNITED STATES, May 10, 2024 /EINPresswire.com/ -- Allied Market Research published a report, titled, "Animal Vaccines Market by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines) and Animal Type (Companion Animal, Livestock Animal, and Aquaculture): Global Opportunity Analysis and Industry Forecast, 2021โ2030." According to the report, the global animal vaccines industry generated $9.09 billion in 2020, and is expected to reach $15.20 billion by 2030, growing at a CAGR of 5.2% from 2020 to 2030.
๐ ๐จ๐ซ ๐๐ข๐ ๐ก๐ญ ๐๐๐ซ๐ฌ๐ฉ๐๐๐ญ๐ข๐ฏ๐ ๐๐ง๐ ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/1988
๐๐ซ๐ข๐ฆ๐ ๐๐๐ญ๐๐ซ๐ฆ๐ข๐ง๐๐ง๐ญ๐ฌ ๐จ๐ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก
Growth in demand for pet insurance, rise in prevalence of animal diseases, surge in expenditure for animal health, and increase in ownership of companion animal drive the growth of the global animal vaccines market. However, highly competitive meat and milk prices and adverse impact of veterinary vaccines on human and animal health hinders the market growth. On the other hand, advancement in vaccine product and rise in demand for hybrid animal create new opportunities in coming years.
๐๐จ๐ฏ๐ข๐-๐๐ ๐๐๐๐ง๐๐ซ๐ข๐จ
The emergence of covid-19 affected the animal vaccine market negatively. The veterinary organizations across the globe have recommended limiting animal patient care to acutely ill animals and emergencies.
The lockdown measures have led to rescheduling of annual checkup exams and elective vaccination procedures. The supply of animal vaccination witnessed disruptions to certain point. However, the manufacturers ensured proper supply of animal vaccinations.
The attenuated vaccines segment to maintain its dominant position during the forecast period
Based on product, the attenuated vaccines a segment held the highest market share in 2020, accounting for nearly two-fifths of the global animal vaccines market, and is expected to maintain its dominant position during the forecast period. This is attributed to availability of advanced technology for specific mutations/deletions in genes of the virus. However, the DNA vaccines segment is estimated to witness the highest CAGR of 8.10% from 2020 to 2030, owing to increase in prevalence of animal diseases, and its easy manipulation as compared to traditional vaccines.
๐๐ซ๐จ๐๐ฎ๐ซ๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ฐ : https://www.alliedmarketresearch.com/animal-vaccines-market/purchase-options
๐๐ก๐ ๐ฅ๐ข๐ฏ๐๐ฌ๐ญ๐จ๐๐ค ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐ฅ๐๐๐๐๐ซ๐ฌ๐ก๐ข๐ฉ ๐ฌ๐ญ๐๐ญ๐ฎ๐ฌ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ซ๐๐ฏ๐๐ง๐ฎ๐ ๐๐ฒ ๐๐๐๐
Based on animal type, the livestock animal segment accounted for nearly than two-thirds of the global animal vaccines market in 2020, and is projected to maintain its leadership status based on revenue by 2030. Increase in the prevalence of various infectious diseases among livestock animals and surge in awareness related to importance of immunization. However, the companion animal segment is expected to portray the highest CAGR of 5.50% from 2020 to 2030. The increase in awareness regarding medical illnesses & ailments of companion animals and growth in animal healthcare expenditure worldwide drive the growth of the segment.
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐ก๐ข๐ ๐ก๐๐ฌ๐ญ ๐๐จ๐ง๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐จ๐ฎ๐ญ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐
Based on region, North America held the majority share in 2020, with nearly two-fifths of the total share of the global animal vaccines market, and will maintain its highest contribution throughout the forecast period. This is due to established veterinary organizational structures and concern amongst people to ensure animal health. However, Asia-Pacific is expected to maintain the highest CAGR of 5.90% during the forecast period, owing to increase in need of protection of livestock from mass wipeouts due to epidemics, especially in countries such as India.
๐๐จ ๐๐จ๐ฎ ๐๐๐ฏ๐ ๐๐ง๐ฒ ๐๐ฎ๐๐ซ๐ฒ ๐๐ซ ๐๐ฉ๐๐๐ข๐๐ข๐ ๐๐๐ช๐ฎ๐ข๐ซ๐๐ฆ๐๐ง๐ญ? ๐๐ฌ๐ค ๐ญ๐จ ๐๐ฎ๐ซ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฑ๐ฉ๐๐ซ๐ญ:
https://www.alliedmarketresearch.com/purchase-enquiry/1988
๐๐จ๐ฉ ๐๐๐๐๐ข๐ง๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ
โช๏ธ Merck & Co., Inc.
โช๏ธ Zoetis Inc.
โช๏ธ Ceva Santรฉ Animale
โช๏ธ Sanofi S.A.
โช๏ธ Romvac
โช๏ธ Vaxxinova
โช๏ธ Biovac
โช๏ธ Merial
โช๏ธ Boehringer Ingelheim GmbH
โช๏ธ Anicon Labor GmbH
๐๐ฒ ๐๐๐ ๐ข๐จ๐ง ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
๐ก๐ผ๐ฟ๐๐ต ๐๐บ๐ฒ๐ฟ๐ถ๐ฐ๐ฎ
(U.S., Canada, Mexico)
๐๐๐ฟ๐ผ๐ฝ๐ฒ
(Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
๐๐๐ ๐๐
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Market Research
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.